Supplement GMP Inspections Slowing As FDA Makes 'Potential' Data Useful

FDA doesn't expect o continue increasing GMP inspections at the rate established from fiscal 2013 through 2017, says Cara Welch, assistant director of the office in the agency's Office of Dietary Supplement Programs."We're not going to keep growing at that rate because we have a lot of regulations we have to inspect and we're always resource strapped," she said at a recent industry conference.

FDA doesn't have resources to continue inspecting more dietary supplement facilities every year but it has ample data to increase the effectiveness of the inspections.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

ProBiotix Health Looks To Next Level In Korea’s $450m Probiotics Market

 
• By 

Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By 

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

Evidence Doesn’t Scratch Substantiation Itch In NAD Review Of MagniLife Gel Pain Relief Claims

 

National Advertising Division finds Magni Group didn’t support claims made on MagniLife Gel packaging, in direct-mail advertisements and online and in social media “Rapid Pain Relief.”

SFI Expands Distribution Of Brain Health Supplement In Europe

 
• By 

Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.

More from Business

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By 

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

Azelis Grows Nutraceuticals Offering In Iberia With Solchem

 
• By 

Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.

Australia’s Wellnex Life Poised To Enter UK’s CHC Market

 
• By 

Wellnex bringing brands such as Pain Away, Wakey Wakey and Nighty Night to UK market shortly after gaining admission to the the AIM market of the London Stock Exchange.